Yahoo Finance Live anchor Brian Cheung takes a look at markets and Nasdaq leaders ahead of the closing bell. Read More...
American City Business Journals
Oregon biotech Siga Technologies set to deliver first monkeypox treatment
Four years after Siga Technologies (Nasdaq: SIGA) gained approval for a smallpox drug, the Corvallis company is gearing up to get the same antiviral into a clinical trial for monkeypox. Tpoxx, also known as tecovirimat, is the only drug available to treat the virus, though it is not yet approved in the U.S. for the disease. The Food and Drug Administration designated Tpoxx as an investigational drug for monkeypox, allowing it to be released from the Strategic National Stockpile only after prescribers jump through considerable hoops.
